Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum

References

• Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005;11:527–39
   PubMed Web of Science ®Google Scholar
• Fairweather DV. Nausea and vomiting in pregnancy. Am J Obstet Gynecol 1968;102:135–75
   PubMed Web of Science ®Google Scholar
• Tsang IS, Katz VL, Wells SD. Maternal and fetal outcomes in hyperemesis gravidarum. Int J Gynaecol Obstet 1996;55:231–5
   PubMed Web of Science ®Google Scholar
• Bailit JL. Hyperemesis gravidarium: epidemiologic findings from a large cohort. Am J Obstet Gynecol 2005;193:811–14
   PubMed Web of Science ®Google Scholar
• Veenendaal MV, van Abeelen AF, Painter RC, et al. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG 2011;118:1302–13
   PubMed Web of Science ®Google Scholar
• Demir B, Erel CT, Haberal A, et al. Adjusted leptin level (ALL) is a predictor for hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 2006;124:193–6
   PubMed Web of Science ®Google Scholar
• Panesar NS, Li CY, Rogers MS. Are thyroid hormones or hCG responsible for hyperemesis gravidarum? A matched paired study in pregnant Chinese women. Acta Obstet Gynecol Scand 2001;80:519–24
   PubMed Web of Science ®Google Scholar
• Derbent AU, Yanik FF, Simavli S, et al. First trimester maternal serum PAPP-A and free beta-HCG levels in hyperemesis gravidarum. Prenat Diagn 2011;31:450–3
   PubMed Web of Science ®Google Scholar
• Taskin S, Taskin EA, Seval MM, et al. Serum levels of adenosine deaminase and pregnancy-related hormones in hyperemesis gravidarum. J Perinat Med 2009;37:32–5
   PubMed Web of Science ®Google Scholar
• Minagawa M, Narita J, Tada T, et al. Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell Immunol 1999;196:1–13
   PubMed Web of Science ®Google Scholar
• Hanus LO. Discovery and isolation of anandamide and other endocannabinoids. Chem Biodivers 2007;4:1828–41
   PubMed Web of Science ®Google Scholar
• Gaoni Y, Mechoulam R. The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 1971;93:217–24
   PubMed Web of Science ®Google Scholar
• Liu J, Wang L, Harvey-White J, et al. A biosynthetic pathway for anandamide. Proc Natl Acad Sci U S A 2006;103:13345–50
   PubMed Web of Science ®Google Scholar
• Dinh TP, Carpenter D, Leslie FM, et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 2002;99:10819–24
   PubMed Web of Science ®Google Scholar
• Saario SM, Laitinen JT. Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol. Chem Biodivers 2007;4:1903–13
   PubMed Web of Science ®Google Scholar
• Jonsson KO, Vandevoorde S, Lambert DM, et al. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol 2001;133:1263–75
   PubMed Web of Science ®Google Scholar
• Garcia Mdel C, Adler-Graschinsky E, Celuch SM. Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide. Eur J Pharmacol 2009;610:75–80
   PubMed Web of Science ®Google Scholar
• Tramer MR, Carroll D, Campbell FA, et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. Br Med J 2001;323:16–21
   PubMed Web of Science ®Google Scholar
• Sharkey KA, Cristino L, Oland LD, et al. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur J Neurosci 2007;25:2773–82
   PubMed Web of Science ®Google Scholar
• Chouker A, Kaufmann I, Kreth S, et al. Motion sickness, stress and the endocannabinoid system. PLoS One 2010;5:e10752
   PubMed Web of Science ®Google Scholar
• Habayeb OM, Taylor AH, Evans MD, et al. Plasma levels of the endocannabinoid anandamide in women–a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab 2004;89:5482–7
   PubMed Web of Science ®Google Scholar
• Habayeb OM, Taylor AH, Finney M, et al. Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. J Am Med Assoc 2008;299:1135–6
   PubMed Web of Science ®Google Scholar
• Marczylo TH, Lam PM, Nallendran V, et al. A solid-phase method for the extraction and measurement of anandamide from multiple human biomatrices. Anal Biochem 2009;384:106–13
   PubMed Web of Science ®Google Scholar
• GraphPad Prism, version 5.00; GraphPad Software: San Diego, CA, 2009
   Google Scholar
• Darmani N. Cannabinoid-induced hyperemesis: a conundrum-from linical recognition to basic science mechanisms. Pharmaceuticals 2010;3:2163–77
   Google Scholar
• Gasperi V, Fezza F, Spagnuolo P, et al. Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. Neurotoxicology 2005;26:811–17
   PubMed Web of Science ®Google Scholar
• Aka N, Atalay S, Sayharman S, et al. Leptin and leptin receptor levels in pregnant women with hyperemesis gravidarum. Aust N Z J Obstet Gynaecol 2006;46:274–7
   PubMed Web of Science ®Google Scholar
• Unsel N, Benian A, Erel CT. Leptin levels in women with hyperemesis gravidarum. Int J Gynaecol Obstet 2004;84:162–63
   PubMed Web of Science ®Google Scholar
• Arslan EO, Cengiz L, Arslan M. Thyroid function in hyperemesis gravidarum and correlation with serum leptin levels. Int J Gynaecol Obstet 2003;83:187–8
   PubMed Web of Science ®Google Scholar
• Karasu T, Marczylo T, Lam P, et al. Does ethnicity influence the plasma levels of the endocannabinoid anandamide. Society of gynecologic investigation; 2011 Mar 20–23; Miami. Reprod Sci 2011;18:254A–5A
   Google Scholar
• Habayeb OM, Taylor AH, Evans MD, et al. Plasma levels of the endocannabinoid anandamide in women – a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab 2004;89:5482–7
   PubMed Web of Science ®Google Scholar